Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Dexmedetomidine.
- Who it may be relevant to
- Registry conditions: Pain Management. Basic parameters: 18 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Different Doses of Dexmedetomidine Added to Local Anesthetic in Sonographic Guided Erector Spinae Plane Block for Pain Management After Renal Surgeries : Randomized Clinical Trial
Overview
to investigate the postoperative analgesic effect of dexmedetomidine addition with different doses as an adjuvant to bupivacaine to Erector spinae plane block after renal surgeries.
Interventions
- Drug Dexmedetomidine
different doses of dexmedetomidine added to bupivacaine in erector spinae plane block
Primary outcome measures
- postoperative analgesic duration [Time frame: 24 hours]
Secondary outcome measures (3)
- Pain score [Time frame: 24 hours]
- side effects [Time frame: 24 hours]
- dynamic pain score [Time frame: 24 hours]
Eligibility criteria
Inclusion criteria
- Age between 18 and 70 years.
- Both sexes, males and females.
- Patients with the American Society of Anesthesiologists (ASA) physical status I/II.
- Body mass index (BMI) of 18-35 kg/m2
- Patients scheduled for elective Renal or Percutaneous Nephrolithotomy.
Exclusion criteria
- Patients under 18 years.
- Patient refusal of nerve block.
- Infection at the site of injection.
- Coagulopathy.
- Allergy to used medications.
- Psychiatric disorder or chronic pain syndromes.
- Chronic opioid use or substance abuse.
- Quadriplegic patients.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Assiut University Hospitals — Asyut
Identifiers
NCT: NCT06899841 · 04-2024-200943